{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["2(Suppl 3)"],"submitter":["Slingluff C"],"journal":["Journal for immunotherapy of cancer"],"pagination":["P60-P60"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4288705"],"repository":["biostudies-literature"],"pubmed_title":["A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes"],"pmcid":["PMC4288705"],"pubmed_authors":["Chianese-bullock K","Smolkin M","Hornillo A","Grosh W","Slingluff C","Weiss G","Galeassi N","Petroni G","Olson W","Smith K","Scott K"],"additional_accession":[]},"is_claimable":false,"name":"A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes","description":null,"dates":{"release":"2014-01-01T00:00:00Z","publication":"2014 Jan","modification":"2025-04-22T07:19:32.615Z","creation":"2025-04-05T22:02:57.492Z"},"accession":"S-EPMC4288705","cross_references":{}}